- Hyaluronidase is an extracellular‑matrix‑degrading enzyme widely used in biological research, tissue processing, cell isolation, and clinical applications. Its primary function is to break down hyaluronic acid, a major glycosaminoglycan responsible for maintaining tissue hydration, elasticity, and structural integrity. By cleaving glycosidic bonds within hyaluronic acid, hyaluronidase reduces viscosity and loosens the extracellular matrix, enabling efficient dissociation of tissues and improved penetration of reagents or therapeutic molecules. This controlled enzymatic activity makes hyaluronidase indispensable in workflows involving tissue dissociation, cell isolation, organoid preparation, and primary‑cell expansion.
- Hyaluronidase is commonly used to process tissues such as skin, adipose tissue, brain, and reproductive organs. In neuroscience, it assists in dissociating brain tissue by breaking down extracellular matrix components that restrict cell separation. In stem‑cell and regenerative‑medicine workflows, hyaluronidase supports isolation of mesenchymal stem cells from adipose tissue and bone marrow, improving yield and viability. In reproductive biology, the enzyme is used to remove cumulus cells surrounding oocytes, enabling fertilisation studies and assisted‑reproduction procedures. Its ability to reduce extracellular matrix viscosity also makes it valuable in drug‑delivery research, where it enhances diffusion of therapeutic agents through tissues. Clinically, hyaluronidase is used to increase absorption of subcutaneous injections, manage extravasation injuries, and dissolve hyaluronic‑acid fillers in dermatology.
- Several manufacturers produce high‑quality hyaluronidase formulations suitable for research and clinical use. Sigma‑Aldrich offers bovine‑testes and microbial hyaluronidase variants widely used in tissue‑dissociation protocols. Worthington Biochemical Corporation manufactures highly purified hyaluronidase used in cell‑isolation workflows, reproductive‑biology studies, and enzymatic tissue‑digestion kits. STEMCELL Technologies provides hyaluronidase as part of specialised dissociation kits designed for organoids and primary‑cell isolation. Gibco supplies hyaluronidase in combination with collagenase and dispase for efficient dissociation of complex tissues, particularly in stem‑cell and regenerative‑medicine workflows. These formulations vary in purity, activity, and regulatory suitability, allowing researchers to select the optimal reagent for their specific tissue type and downstream application.
- Effective use of hyaluronidase requires careful attention to temperature, incubation time, and reagent concentration. Pre‑warming the enzyme solution improves activity, while combining hyaluronidase with complementary enzymes enhances dissociation of dense or fibrous tissues. Digestion should be monitored under a microscope to avoid over‑digestion, which can damage cells or reduce viability. Enzymatic activity must be neutralised promptly using serum‑containing medium or appropriate inhibitors. Gentle mechanical agitation and sterile technique further support reproducible and high‑viability dissociation outcomes. When used correctly, hyaluronidase provides reliable, efficient, and reproducible dissociation suited to a wide range of biological and clinical applications.
- Overall, hyaluronidase remains a cornerstone of tissue‑processing workflows in biology and medicine. Its ability to break down hyaluronic acid and reduce extracellular matrix viscosity supports high‑quality research across neuroscience, reproductive biology, stem‑cell science, dermatology, and drug‑delivery studies. Whether used alone or in combination with other enzymes, hyaluronidase provides controlled, efficient, and gentle dissociation that preserves cell viability and supports downstream experimental success.
